SCIENCE THROUGH NETWORKING

WHAT ARE THE ATMPS

 

The definition of advanced therapies (ATMPs) includes a heterogeneous series of medicinal products. The European Medicines Agency (EMA) defines as advanced therapies:

  • Gene therapies: medicinal products containing recombinant nucleic acid as active substance thus to regulate, repair, replace, add or delete a genetic sequence or medicinal products whose therapeutic / prophylactic / diagnostic effect relates directly to the recombinant nucleic acid sequence or to its product of genetic expression.
  • Somatic cell therapy medicinal products: cells substantially manipulated to acquire specific biological properties or cells/ tissues not intended to be used for the same essential functions in the body.
  • Tissue engineered products:  cells or tissues grown on 3D scaffold so they can be used to repair, regenerate or replace human tissue. 

WHO WE ARE

 

ATMP FORUM is a virtual agorà where all stakeholders can directly interact and discuss on ATMPs clinical, economical and organizational advances and issues. An efficient and sustainable access to advanced therapy as well as the promotion of public-private partnership are a win win goal and priority for all the actors involved and patients first. 

Our aim is to improve Italian experience and expertise to make our Country a leader of ATMPs scenario and we are working for this. 


SCIENTIFIC BOARD

 

Pier Luigi Canonico (Chair)
Director of Pharmaceutical Sciences Department and Full Professor of Pharmacology, Università del Piemonte Orientale (UPO), Novara
Elena Paola Lanati
ATMP Forum Director, Milan
Alessandro Aiuti
Professor of Pediatrics, Università Vita Salute San Raffaele; Vice-Director of San Raffaele Telethon Institute for Gene Therapy, Milan
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Giorgio Calesella
Lawyer Studio Legale Calesella, Milan
Rachele Ciccocioppo
Associate Professor in Gastroenterology, Università degli Studi di Verona
Claudio Jommi
Scientific Director of the Pharmaceutical Observatory at Cergas SDA Bocconi University, Milan and Associate Professor of Management at the Department of Pharmaceutical Sciences, Università del Piemonte Orientale (UPO), Novara
Cecilia Maini
Life Sciences Regional Technology Platform Coordinator Aster, Bologna
Enrica Morra
Chair or Lombardy Region Haematological Network (REL), Milan
Maria Luisa Nolli
Member of the board of Assobiotec and EUROPABIO, Rome
Marcello Pani
Member of Executive Board of Italian Society of Hospital Pharmacy (SIFO)
Concetta Quintarelli
Researcher, Department of Pediatric Onco-Haematology and Transfusion Medicine Pediatric Hospital Bambin Gesù, Rome
Anna Paola Salvetti
Researcher, Dept. of Biomedical and Clinical Sciences “Luigi Sacco”, Università degli Studi di Milano
Andrea Sodi
Dept. Ophtalmology, Careggi Hospital, Florence; Secretary of Italian Society of Genetic Ophtalmlogy (SIOG)

With the unconditional support of

 

Celgene logo P280
galta ris
novartis logo pos cmyk c

 

Sanofi genzymePNG
Takeda Symbol Color pos

We use cookies, just to track visits to our website, we store no personal details